The Lancet Diabetes & Endocrinology in conversation with

Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D

July 09, 2021 The Lancet Diabetes & Endocrinology
The Lancet Diabetes & Endocrinology in conversation with
Hertzel Gerstein on dulaglutide, erectile dysfunction, and T2D
Show Notes

Hertzel Gerstein talks with The Lancet Diabetes & Endocrinology about how dulaglutide might reduce the incidence of moderate or severe erectile dysfunction in men with type 2 diabetes.

Read the full article: 
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(21)00115-7/fulltext

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv